Table 3.
Presence of safety-related information on medication package inserts (n = 200).
| Variables | Frequency | Percentage |
|---|---|---|
| Adverse drug reactions | 191 | 95.5 |
| Contraindications | 189 | 94.5 |
| Drug-drug interactions | 160 | 80.0 |
| Drug-food interactions | 42 | 21.0 |
| Pregnancy considerations | 154 | 77.0 |
| Lactation considerations | 148 | 74.0 |
| Pediatric considerations | 141 | 70.5 |
| Geriatric considerations | 75 | 37.5 |
| Special warning and precautions∗ | 99 | 49.5 |
| Abuse/dependence property | 7 | 3.5 |
| Effect on the ability to drive and operate machines | 69 | 34.5 |
| Overdose and management | 139 | 69.5 |
| Maximum dose | 54 | 27.0 |
| Missing dose | 52 | 26.0 |
| Handling and disposal | 45 | 22.5 |
∗ Example: renal, hepatic, cardiac, or nutritional insufficiencies that require either increased or reduced dosage.